Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of Obesity in Adolescents and Young Adults
NCT06905626Phase 3Recruiting
- Sponsor
- University of Minnesota
- Start
- Jan 2027
- Primary completion
- Oct 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in obesity comparing Qsymia arm with Placebo arm (2 arms). Primary endpoint: Body Mass Index at 24 months. Planned start Jan 2027; status: recruiting.
02
Drugs
phentermine + topiramate
03
Conditions
obesity
Beyond the preview
Go deeper on NCT06905626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06905626.